Mitchell Sinkler & Starr Gsk PLC Transaction History

Mitchell Sinkler & Starr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 13, 2018	SELL	$36.18 - $40.15 $210,676 - $233,793	-5,823 Closed	0 $0
Q4 2017 Jan 11, 2018	SELL	$35.34 - $41.9 $53,010 - $62,850	-1,500 Reduced 20.48%	5,823 $207,000
Q3 2017 Oct 23, 2017	BUY	$39.44 - $41.55 $288,819 - $304,270	7,323	7,323 $297,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

Stay updated on Mitchell Sinkler & Starr with notifications on news.